Federation des caisses Desjardins du Quebec’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,226
Closed -$207K 2195
2017
Q3
$207K Buy
13,226
+7,462
+129% +$117K ﹤0.01% 1007
2017
Q2
$80.9K Buy
+5,764
New +$80.9K ﹤0.01% 1271